Real-time SEC alerts Start Free →
Profitelligence
Cencora Inc.
COR MEDIUM Impact

Cencora Inc.

Cencora Announces Pricing of Senior Notes and Underwriting Agreement

| 8-K |Healthcare

Summary

On December 2, 2024, Cencora, Inc. priced $500 million of 4.625% Senior Notes due 2027, $600 million of 4.850% Senior Notes due 2029, and $700 million of 5.150% Senior Notes due 2035. The offering is part of an underwritten public offering, with proceeds intended for the acquisition of Retina Consultants of America and other corporate purposes. The underwriting agreement was entered into with BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC, and Wells Fargo Securities, LLC. The offering is expected to close on December 9, 2024.

Profitelligence Profitelligence Alerts

Get alerts for COR

Be first to know when Cencora Inc. files with the SEC.

Set Up Alerts →

Filing Categories

Regulation FD Disclosure Share Repurchase Program Announced Exhibits Furnished

Exhibits (2)

Advertisement

About Cencora Inc.

Cencora Inc., formerly known as AmerisourceBergen Corporation, represents a pivotal entity in the global healthcare distribution and services sector. As a leading pharmaceutical sourcing and distribution services company, Cencora Inc. plays a critical role in ensuring the efficient supply of pharmaceutical products to a range of healthcare providers, including hospitals, pharmacies, and clinics. Its business model is centered on the seamless integration of logistics, consulting services, and the provision of innovative solutions aimed at improving pharmaceutical supply chain operations. Cencora Inc. impacts various segments of the healthcare industry by enhancing the availability and accessibility of healthcare products. Known for its global reach and extensive network of distribution centers, the company supports the delivery of critical medications and healthcare products across numerous geographies. Cencora Inc.'s significance in the market is underscored by its ability to partner with pharmaceutical manufacturers and healthcare providers to streamline processes, reduce costs, and improve patient outcomes. Headquartered in Conshohocken, Pennsylvania, Cencora Inc. remains a cornerstone of the healthcare distribution market, focusing on sustainability, innovation, and strategic collaborations.

Exchange: NYSE Industry: Medical Distribution Company Website →

Official SEC Documents

COR
COR Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement